Effect of Chronic Angiotensin‐Converting Enzyme Inhibition on Striatal Dopamine Content in the MPTP‐Treated Mouse
Open Access
- 1 July 1999
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 73 (1) , 214-219
Abstract
We have previously shown that chronic treatment with the angiotensin‐converting enzyme inhibitor perindopril increased striatal dopamine levels by 2.5‐fold in normal Sprague—Dawley rats, possibly via modulation of the striatal opioid or tachykinin levels. In the present study, we investigated if this effect of perindopril persists in an animal model of Parkinson’s disease, the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mouse. C57BL/6 mice were treated with the neurotoxin (30 mg/kg/day intraperitoneally) for 4 days and then left for 3 weeks to allow the degeneration of striatal dopaminergic terminals. At this time, the mice exhibited a 40% decrease in striatal dopamine content and an accompanying 46% increase in dopamine D2 receptor levels compared with control untreated mice. The dopamine content returned to control levels, and the increase in dopamine D2 receptor levels was attenuated in mice treated with perindopril (5 mg/kg/day orally for 7 days) 2 weeks after the last dose of MPTP. When the angiotensin‐converting enzyme inhibitor was administered (5 mg/kg/day for 7 days) immediately after the cessation of the MPTP treatment, there was no reversal of the effect of the neurotoxin in decreasing striatal dopamine content. Our results demonstrate that perindopril is an effective agent in increasing striatal dopamine content in an animal model of Parkinson’s disease.Keywords
This publication has 18 references indexed in Scilit:
- Angiotensin‐Converting Enzyme Modulates Dopamine Turnover in the StriatumJournal of Neurochemistry, 1997
- Changes in dopamine D1 and D2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin)Neuroscience Letters, 1992
- MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)Brain Research, 1990
- Rapid Determination of Norepinephrine, Dopamine, Serotonin, Their Precursor Amino Acids, and Related Metabolites in Discrete Brain Areas of Mice Within Ten Minutes by HPLC with Electrochemical DetectionJournal of Neurochemistry, 1988
- Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black miceBrain Research, 1987
- Effects of nigral dopaminergic lesions and striatal excitotoxin lesions on brain converting enzymeNeurochemistry International, 1987
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390Brain Research, 1986
- Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the catBrain Research, 1983
- Stimulation of Dopamine Synthesis in Caudate Nucleus by Intrastriatal Enkephalins and Antagonism by NaloxoneScience, 1978